AI assistant
Anika Therapeutics, Inc. — Director's Dealing 2012
Mar 8, 2012
33997_dirs_2012-03-08_ac09f969-bdbd-480d-afcf-2ac71480c0b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANIKA THERAPEUTICS INC (ANIK)
CIK: 0000898437
Period of Report: 2012-03-01
Reporting Person: LUPPINO FRANCESCO J (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-01 | Stock Option (Right to Buy) | $6.99 | A | 37500 | Acquired | 2022-03-01 | Common Stock (37500) | Direct |
Footnotes
F1: The exercise price of the stock options represents the closing price of the Company's common stock on June 7, 2011, the date the Board of Directors of the Company granted performance-based stock option awards (the "Performance Grant") and approved the performance measures governing such Performance Grant.
F2: The stock options were issued under the Performance Grant on March 1, 2012, the date the Compensation Committee of the Company determined that certain performance measures governing the Performance Grant were achieved.
F3: The stock options vest in three equal installments as follows: March 1, 2012, January 1, 2013, and January 1, 2014